There is currently no cure for muscular dystrophies, although several promising strategies are in basic and clinical research. One such strategy is cell transplantation with satellite cells (or their myoblast progeny) to repair damaged muscle and provide dystrophin protein with the aim of preventing subsequent myofibre degeneration and repopulating the stem cell niche for future use. The present review aims to cover recent advances in satellite cell/myoblast therapy and to discuss the challenges that remain for it to become a realistic therapy
AbstractMuscle satellite cells have long been considered a distinct myogenic lineage responsible for...
After birth, skeletal muscle retains its ability to regenerate from a population of muscle stem cell...
The satellite cells are long regarded as heterogeneous cell population, which is intimately linked t...
Understanding stem cell commitment and differentiation is a critical step towards clinical translati...
AbstractMuscular dystrophies comprise a heterogeneous group of neuromuscular disorders, characterize...
PhD ThesisMuscular dystrophies are a category of diseases in which the muscle fibres degrade over ti...
Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and ca...
Treating muscle disorders poses several challenges to the rapidly evolving field of regenerative med...
Genetic mutations in muscle structural genes can compromise myofiber integrity, causing repeated mus...
Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders, in which progressive mu...
Stem cell transplantation is already in clinical practice for certain genetic diseases and is a prom...
AbstractDuchenne muscular dystrophy is an inherited disorder that is characterized by progressive sk...
Abstract Skeletal muscle regeneration is the process that ensures tissue repair after damage by inju...
Muscular dystrophies are heritable, heterogeneous neuromuscular disorders and include Duchenne and B...
Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective ...
AbstractMuscle satellite cells have long been considered a distinct myogenic lineage responsible for...
After birth, skeletal muscle retains its ability to regenerate from a population of muscle stem cell...
The satellite cells are long regarded as heterogeneous cell population, which is intimately linked t...
Understanding stem cell commitment and differentiation is a critical step towards clinical translati...
AbstractMuscular dystrophies comprise a heterogeneous group of neuromuscular disorders, characterize...
PhD ThesisMuscular dystrophies are a category of diseases in which the muscle fibres degrade over ti...
Multipotent cells that can give rise to bone, cartilage, fat, connective tissue, and skeletal and ca...
Treating muscle disorders poses several challenges to the rapidly evolving field of regenerative med...
Genetic mutations in muscle structural genes can compromise myofiber integrity, causing repeated mus...
Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders, in which progressive mu...
Stem cell transplantation is already in clinical practice for certain genetic diseases and is a prom...
AbstractDuchenne muscular dystrophy is an inherited disorder that is characterized by progressive sk...
Abstract Skeletal muscle regeneration is the process that ensures tissue repair after damage by inju...
Muscular dystrophies are heritable, heterogeneous neuromuscular disorders and include Duchenne and B...
Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective ...
AbstractMuscle satellite cells have long been considered a distinct myogenic lineage responsible for...
After birth, skeletal muscle retains its ability to regenerate from a population of muscle stem cell...
The satellite cells are long regarded as heterogeneous cell population, which is intimately linked t...